These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. A case of neuroleptic malignant syndrome with clozapine and risperidone. Beauchemin MA; Millaud F; Nguyen KA Can J Psychiatry; 2002 Nov; 47(9):886. PubMed ID: 12500761 [No Abstract] [Full Text] [Related]
36. Clinical profile of an atypical antipsychotic: risperidone. Davis JM; Chen N Schizophr Bull; 2002; 28(1):43-61. PubMed ID: 12047021 [TBL] [Abstract][Full Text] [Related]
37. Contribution of leptin to the formation of neuroleptic obesity in patients with schizophrenia during antipsychotic therapy. Gorobets LN Bull Exp Biol Med; 2008 Sep; 146(3):348-50. PubMed ID: 19240857 [TBL] [Abstract][Full Text] [Related]
38. The rabbit syndrome: state of the art. Catena M; Fagiolini A; Consoli G; Ducci F; Carlini M; Picchetti M; Marazziti D Curr Clin Pharmacol; 2007 Sep; 2(3):212-6. PubMed ID: 18690867 [TBL] [Abstract][Full Text] [Related]
39. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia. Srivastava A; Borkar HA; Chandak S Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992 [TBL] [Abstract][Full Text] [Related]
40. Neuroleptic malignant syndrome after neuroleptic discontinuation. Amore M; Zazzeri N Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]